Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Three-year follow-up of anthracycline-induced cardiotoxicity risk in breast cancer patients using the HFA-ICOS score

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Who is at risk of cardiovascular toxicity?

Access
Like
Thumbnail

Prescribing SGLT2 inhibitors in acute heart failure: considerations for dysglycemia status, heart failure phenotype, and kidney function

Event: Heart Failure 2024

Topic: Antidiabetic Pharmacotherapy

Session: ePosters in interventional cardiology and pharmacology 2

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources